Latest Integral Health Asset Management, LLC Stock Portfolio
Integral Health Asset Management, LLC Performance:
2025 Q3: 21.82%YTD: 24.4%2024: 14.7%
Performance for 2025 Q3 is 21.82%, and YTD is 24.4%, and 2024 is 14.7%.
About Integral Health Asset Management, LLC and 13F Hedge Fund Stock Holdings
Integral Health Asset Management, LLC is a hedge fund based in NEW YORK, NY. On 24-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $656.1 Millions. In it's latest 13F Holdings report, Integral Health Asset Management, LLC reported an equity portfolio of $1.5 Billions as of 30 Sep, 2025.
The top stock holdings of Integral Health Asset Management, LLC are INSM, CYTK, THC. The fund has invested 15.6% of it's portfolio in INSMED INC and 5.2% of portfolio in CYTOKINETICS INC.
The fund managers got completely rid off DEXCOM INC (DXCM), GE HEALTHCARE TECHNOLOGIES I and 89BIO INC (ETNB) stocks. They significantly reduced their stock positions in UNIQURE NV (QURE), CHARLES RIV LABS INTL INC (CRL) and BOSTON SCIENTIFIC CORP (BSX). Integral Health Asset Management, LLC opened new stock positions in CENTENE CORP DEL (CNC), DOXIMITY INC (DOCS) and ARCELLX INC (ACLX). The fund showed a lot of confidence in some stocks as they added substantially to OSCAR HEALTH INC (OSCR), ALIGNMENT HEALTHCARE INC (ALHC) and ELANCO ANIMAL HEALTH INC (ELAN).
The top stock holdings of Integral Health Asset Management, LLC are INSM, CYTK, THC. The fund has invested 15.6% of it's portfolio in INSMED INC and 5.2% of portfolio in CYTOKINETICS INC.
The fund managers got completely rid off DEXCOM INC (DXCM), GE HEALTHCARE TECHNOLOGIES I and 89BIO INC (ETNB) stocks. They significantly reduced their stock positions in UNIQURE NV (QURE), CHARLES RIV LABS INTL INC (CRL) and BOSTON SCIENTIFIC CORP (BSX). Integral Health Asset Management, LLC opened new stock positions in CENTENE CORP DEL (CNC), DOXIMITY INC (DOCS) and ARCELLX INC (ACLX). The fund showed a lot of confidence in some stocks as they added substantially to OSCAR HEALTH INC (OSCR), ALIGNMENT HEALTHCARE INC (ALHC) and ELANCO ANIMAL HEALTH INC (ELAN).
Integral Health Asset Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Integral Health Asset Management, LLC made a return of 21.82% in the last quarter. In trailing 12 months, it's portfolio return was 20.65%.
New Buys
| Ticker | $ Bought |
|---|---|
| centene corp del | 14,272,000 |
| doximity inc | 13,167,000 |
| arcellx inc | 12,315,000 |
| ascendis pharma a/s | 11,928,600 |
| envista holdings corporation | 11,203,500 |
| intuitive surgical inc | 11,180,800 |
| upstream bio inc | 10,815,800 |
| dyne therapeutics inc | 10,120,000 |
New stocks bought by Integral Health Asset Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| oscar health inc | 450 |
| alignment healthcare inc | 300 |
| elanco animal health inc | 128 |
| biohaven ltd | 116 |
| exact sciences corp | 100 |
| glaukos corp | 100 |
| rhythm pharmaceuticals inc | 83.33 |
| agilent technologies inc | 80.00 |
Additions to existing portfolio by Integral Health Asset Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| uniqure nv | -55.56 |
| charles riv labs intl inc | -47.83 |
| boston scientific corp | -45.45 |
| mineralys therapeutics inc | -44.44 |
| quest diagnostics inc | -43.33 |
| fresenius medical care ag | -40.00 |
| encompass health corp | -37.5 |
| pfizer inc | -28.57 |
Integral Health Asset Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| 89bio inc | -10,311,000 |
| atyr pharma inc | -5,323,500 |
| jasper therapeutics inc | -3,274,500 |
| arcus biosciences inc | -2,442,000 |
| baxter intl inc | -7,570,000 |
| dexcom inc | -17,458,000 |
| moonlake immunotherapeutics | -9,440,000 |
| ge healthcare technologies i | -14,814,000 |
Integral Health Asset Management, LLC got rid off the above stocks
Sector Distribution
Integral Health Asset Management, LLC has about 85.6% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 85.6 |
| Others | 14.4 |
Market Cap. Distribution
Integral Health Asset Management, LLC has about 45.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 43.6 |
| MID-CAP | 27.7 |
| UNALLOCATED | 14.4 |
| SMALL-CAP | 10.8 |
| MEGA-CAP | 1.5 |
| MICRO-CAP | 1.4 |
Stocks belong to which Index?
About 63.9% of the stocks held by Integral Health Asset Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 44.3 |
| Others | 36.1 |
| S&P 500 | 19.6 |
Integral Health Asset Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Integral Health Asset Management, LLC
Integral Health Asset Management, LLC has 72 stocks in it's portfolio. About 42.5% of the portfolio is in top 10 stocks. INSP proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for Integral Health Asset Management, LLC last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| A | agilent technologies inc | 0.78 | 90,000 | 11,551,500 | added | 80.00 | ||
| ABBV | abbvie inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACHC | acadia healthcare company in | 0.50 | 300,000 | 7,428,000 | reduced | -25.00 | ||
| ACLX | arcellx inc | 0.83 | 150,000 | 12,315,000 | new | |||
| ALHC | alignment healthcare inc | 1.89 | 1,600,000 | 27,920,000 | added | 300 | ||
| ALKS | alkermes plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALNY | alnylam pharmaceuticals inc | 1.85 | 60,000 | 27,360,000 | added | 9.09 | ||
| APLS | apellis pharmaceuticals inc | 0.38 | 250,000 | 5,657,500 | new | |||
| ARWR | arrowhead pharmaceuticals in | 0.52 | 225,000 | 7,760,250 | new | |||
| BAX | baxter intl inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BEAM | beam therapeutics inc | 0.66 | 400,000 | 9,708,000 | reduced | -20.00 | ||
| BSX | boston scientific corp | 1.98 | 300,000 | 29,289,000 | reduced | -45.45 | ||
| CAH | cardinal health inc | 1.38 | 130,000 | 20,404,800 | reduced | -7.14 | ||
| CNC | centene corp del | 0.97 | 400,000 | 14,272,000 | new | |||
| COO | cooper cos inc | 0.44 | 95,000 | 6,513,200 | added | 35.71 | ||
| CPRX | catalyst pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CRL | charles riv labs intl inc | 0.64 | 60,000 | 9,387,600 | reduced | -47.83 | ||
| CRSP | crispr therapeutics ag | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CVS | cvs health corp | 1.02 | 200,000 | 15,078,000 | reduced | -20.00 | ||
| CYTK | cytokinetics inc | 5.21 | 1,400,000 | 76,944,000 | added | 40.00 | ||